SCOR records net income of EUR 189 million in the first half 2013, despite high Nat Cat activity, a continued low yield environment and equity impairments.
SCOR announces the publication of its interim financial report for the six months ended 30 June 2013
SCOR announces the public release and the filing with the Autorité des marches financiers of its interim financial report for the six months ended 30 June 2013.
In this paper, we consider the valuation of the Guaranteed Minimum Withdrawal Benefit (GMWB) option associated with a variable annuity insurance policy.
Brian Shea joins the Group on 22 August 2013 as Chief Corporate Strategy Officer, based in London. He will be in charge of Corporate Strategy and will supervise corporate Communications.
On 26 June 2013 in London, Denis Kessler, Chairman & Chief Executive Officer of SCOR, was named "Reinsurance Company CEO of the Year" at the Reactions London Market Awards.
Malcolm Newman, Managing Director of SCOR’s London Hub, was elected the new Chairman of the International Underwriting Association (IUA) at the association’s annual general meeting on 26 June 2013 in London.
The classical Critical Illness (CI) product has become a standard and mature product offered in many markets around the world. The recent decade has seen a search towards the next generation of product design.
Denis Kessler, Chairman & CEO of SCOR, has been elected 2012 “Financier of the Year”, an award run by ANDESE - the French National Association of Doctors of Economics and Management Science, and the weekly publica
Red blood cell disorders occur as a result of a lack, an excess or a genetic defect in the production of these vital cells. A shortage of red blood cells, or erythrocytes, is evidenced by anaemia.
Red blood cell disorders occur as a result of a lack, an excess or a genetic defect in the production of these vital cells. A shortage of red blood cells, or erythrocytes, is evidenced by anaemia.
Red blood cell disorders occur as a result of a lack, an excess or a genetic defect in the production of these vital cells. A shortage of red blood cells, or erythrocytes, is evidenced by anaemia.